about
Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens.A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancyC-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.Nouvelle cuisine: platelets served with inflammation.C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury.CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia.The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Elevation of C-reactive protein levels in patients with transfusion-related acute lung injury.IgG-effector functions: "the good, the bad and the ugly".A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.Low levels of interleukin-10 in patients with transfusion-related acute lung injury.Alleviation of gram-negative bacterial lung inflammation by targeting HECTD2.HXT5 expression is under control of STRE and HAP elements in the HXT5 promoter.Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report.T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (ITP).Targeting Transfusion-Related Acute Lung Injury: The Journey From Basic Science to Novel Therapies.The nonhemostatic immune functions of platelets.The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung InjuryTransfusion-associated circulatory overload (TACO): Time to shed light on the pathophysiologyMoving target PF4 directs HIT responsesGastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injuryAntiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopeniaMature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to plateletsPlatelets as immune-sensing cellsCoupling porous sheathless interface MS with transient-ITP in neutral capillaries for improved sensitivity in glycopeptide analysisB-cell involvement in chronic graft-versus-host diseaseAnti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacyFcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopeniaThe Role of Complement in Transfusion-Related Acute Lung InjuryThe Ultimate Murine Model of Immune ThrombocytopaeniaAnti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patientsOsteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulationTransfusion-associated circulatory overload and transfusion-related acute lung injuryThrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)Transfusion-related Acute Lung Injury in the Perioperative PatientTreating murine inflammatory diseases with an anti-erythrocyte antibodyAnalysing therapeutic responses in immune thrombocytopaenia: shifting the focus towards immune characteristics
P50
Q33381721-F0C82836-B8D4-4095-87A0-A05FEB748842Q33411528-996BB0FB-0247-4212-B725-6457F2E567B8Q33419534-6040DF90-BCB5-4C5D-BF27-4448EEAFB909Q33423427-1D995CEF-8C3E-4593-A324-51C2B87DA0B6Q33426586-A84BE67E-AE0B-4A19-9F21-99A466B6E68AQ33427450-9911A410-5BB5-4881-A1F8-FA8209E0363FQ33433899-85F12C36-2058-4270-B32F-06B8E829245CQ33437093-ECF3219A-65AC-4502-A51F-30C0B1A2AC57Q33439412-9AF201D4-A54B-450B-8C66-96A01EF3A9F5Q37718487-C9398A0F-7CF1-44F4-B8F3-81393F76C16CQ38185196-2163F1A2-A28C-4358-8EB0-A2C9003BEE57Q40387870-936BC20D-D0F1-497A-A1BB-3D8EECFC75B0Q41486116-4CA11A4A-9A84-42F4-A988-643DA2260929Q42330842-EF15D5DC-E857-4705-93A1-AB3D656BD066Q44999560-E8A77B3F-CCF8-427A-B656-6A2BC58FB9E5Q46064368-C11A610E-D348-4058-A5F4-C03FA92251D5Q47330314-4C04FEF6-C2E3-4704-A687-3358492CD8FDQ47630592-60E5642C-EDE6-4B8A-9941-C97742ADF665Q47642730-B7AAF98A-A170-48A3-B9C6-FB4C65D86426Q54573654-CBA97C08-F32F-42C8-AF10-C4D0EF4F03ABQ57676565-69F8486A-2E8E-4801-BBAB-C1470636958CQ57676567-9BE6B7B9-4484-458D-97D6-81D1BED3BD94Q57676568-B44B35E0-C526-4C5E-8981-E1C9E8B8921FQ57676570-8F8291AA-A5C4-44F7-BEFC-A6302653551FQ57676572-40A8CD06-F75E-4EA3-84FA-66F286FCFA3EQ57676575-387E4A7E-8002-4605-9EA2-9AE3AA71F09CQ57676581-02EE52C1-E5D2-4AE3-A28E-A4B7EF18A35CQ57676590-79D3CB19-56F4-43CF-8348-D10BC0A4C381Q57676591-367B5747-62FD-43B4-B946-B9C30806479CQ89454765-0F6E4CC9-0C8C-4FD5-9412-654CB29F5B28Q89926187-99FFA4CC-7B08-4168-A9BE-72E8D764E2F0Q91060157-1390AB2E-1F0F-46FF-8178-BB0C28A450BFQ91381204-7D85DAF3-2CFB-4664-9093-4841BF490C7EQ91807388-E3007A26-DEA3-446D-A414-51839866337AQ91929042-6AFBBEFD-D308-4540-ABC1-2AC4E1B8D7C8Q91942096-93DE0C91-8954-4DF0-A354-4DDD224FC80EQ92411264-88204F0A-D921-4BB8-81FC-9BFDDF00D33AQ92592999-EE3353EE-A467-437D-A994-A5CE5229BF9CQ92756320-E8657886-547E-4B3E-999C-9E5048D231F3Q93043988-AC051CAC-B11B-4ED0-BC9E-06276CD33AD4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rick Kapur
@ast
Rick Kapur
@en
Rick Kapur
@es
Rick Kapur
@nl
type
label
Rick Kapur
@ast
Rick Kapur
@en
Rick Kapur
@es
Rick Kapur
@nl
prefLabel
Rick Kapur
@ast
Rick Kapur
@en
Rick Kapur
@es
Rick Kapur
@nl
P106
P108
P31
P496
0000-0002-1608-876X